1
|
Afonso MDS, Lopes LPN, Ferreira MM, Ribeiro RADC, Monteiro LDS, Matos APDS, Monteiro MSDSB, Júnior ER, Santos EPD, Abreu LCLD, Freitas ZMFD. Bacaba, Pracaxi and Uxi Oils for Therapeutic Purposes: A Scoping Review. J Oleo Sci 2024; 73:11-23. [PMID: 38171726 DOI: 10.5650/jos.ess23142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2024] Open
Abstract
Fruits such as bacaba (Oenocarpus bacaba Mart), pracaxi (Pentaclethra macroloba Kuntze) and uxi (Endopleura uchi (Huber) Cuatrec), from the Amazon rainforest, are potentially interesting for studies of natural products. The current article aims at mapping and characterizing studies on the bacaba, pracaxi and uxi species. This review reports the main bioactive compounds identified in these species and discusses their therapeutic potential. Searches were performed in MEDLINE (Via Pubmed) and Web of Science. Thirty-one studies that described or evaluated the development of formulations aimed at the therapeutic use of the species were included. The findings suggest that species have the potential for the development of pharmaceutical formulations due to their therapeutic properties. However, further studies are required to assess safety and efficacy of these products. Therefore, it is suggested that new research studies propose strategies so that technological development is based on awareness and preservation of the biome.
Collapse
Affiliation(s)
- Millena de Sousa Afonso
- Graduate Program in Pharmaceutical Science and Technology, Pharmacy School, Federal University of Rio de Janeiro
| | | | | | | | | | | | | | - Eduardo Ricci Júnior
- Graduate Program in Pharmaceutical Science and Technology, Pharmacy School, Federal University of Rio de Janeiro
| | - Elisabete Pereira Dos Santos
- Graduate Program in Pharmaceutical Science and Technology, Pharmacy School, Federal University of Rio de Janeiro
| | | | - Zaida Maria Faria de Freitas
- Graduate Program in Pharmaceutical Science and Technology, Pharmacy School, Federal University of Rio de Janeiro
| |
Collapse
|
2
|
Cesena F. Estratégia Farmacoinvasiva no Infarto do Miocárdio com Supradesnível do Segmento ST no Brasil: Sexo Feminino como Fator Prognóstico. Arq Bras Cardiol 2022; 119:703-704. [DOI: 10.36660/abc.20220688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
3
|
Oliveira GMMD, Almeida MCCD, Marques-Santos C, Costa MENC, Carvalho RCMD, Freire CMV, Magalhães LBNC, Hajjar LA, Rivera MAM, Castro MLD, Avila WS, Lucena AJGD, Brandão AA, Macedo AVS, Lantieri CJB, Polanczyk CA, Albuquerque CJDM, Born D, Falcheto EB, Bragança ÉOV, Braga FGM, Colombo FMC, Jatene IB, Costa IBSDS, Rivera IR, Scholz JR, Melo Filho JXD, Santos MAD, Izar MCDO, Azevedo MF, Moura MS, Campos MDSB, Souza OFD, Medeiros OOD, Silva SCTFD, Rizk SI, Rodrigues TDCV, Salim TR, Lemke VDMG. Position Statement on Women's Cardiovascular Health - 2022. Arq Bras Cardiol 2022; 119:815-882. [PMID: 36453774 PMCID: PMC10473826 DOI: 10.36660/abc.20220734] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Daniel Born
- Escola Paulista de Medicina , São Paulo SP - Brasil
| | | | | | | | | | | | | | - Ivan Romero Rivera
- Hospital Universitário Professor Alberto Antunes / Universidade Federal de Alagoas , Maceió AL - Brasil
| | | | | | | | | | | | | | | | | | | | | | - Stéphanie Itala Rizk
- Instituto do Coração (Incor) do Hospital das Clínicas FMUSP , São Paulo SP - Brasil
| | | | | | | |
Collapse
|
4
|
Machline-Carrion MJ. Superando a Montanha-Russa Hormonal ao Longo da Vida das Mulheres: Um Ponto de Virada para a Prevenção Cardiovascular. Arq Bras Cardiol 2022; 118:914-915. [PMID: 35613190 PMCID: PMC9368890 DOI: 10.36660/abc.20220259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|